The Valley Desk

NCT01672853 · Interventional trial

Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)

Overall registry status Completed

Phase 2

Conditions Primary Sclerosing Cholangitis (PSC)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov